🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David Mauro

University of North Carolina at Chapel Hill

ORCID: 0000-0003-3088-1809
MedicineImmunology and MicrobiologyEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma”.

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

The Oncologist(2024)10.1093/oncolo/oyad331
N/A
1.4DataRank · unranked
46 citations

Menggang Yu, Barry Keane, David Mauro, Paul R. Helft, William Proctor Harris +6 more

Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial

Cancer Cell(2024)10.1016/j.ccell.2024.10.007
N/A
1.3DataRank · unranked
59 citations

Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joë-Marc Chauvin, F. Amatore +48 more

605 Neoadjuvant vidutolimod (vidu) and nivolumab (nivo) results in MPR and immune activation in high-risk resectable melanoma (MEL): final phase II clinical trial results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0605
N/A
0.272DataRank · unranked
4 citations

Joë-Marc Chauvin, Robert Morrison, Yulong Bai, Jie Sun, Hong Wang +22 more

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma

Research Square(2022)10.21203/rs.3.rs-2235839/v1
N/A
0.104DataRank · unranked
1 citations

Arivarasan Karunamurthy, Joë-Marc Chauvin, Robert M. Morrison, Yulong Bai, Jie Sun +40 more

Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study

Hepatology Communications(2023)10.1097/hc9.0000000000000184
N/A
0DataRank · unranked
11 citations

Hannah P. Kim, Amit G. Singal, Dawn Owen, Mishal Mendiratta‐Lala, Neehar D. Parikh +29 more

ACR Appropriateness Criteria® Noncerebral Vasculitis

Journal of the American College of Radiology(2021)10.1016/j.jacr.2021.08.005
N/A
0DataRank · unranked
12 citations

Michael L. Steigner, Ezana Azene, Judah Burns, Panithaya Chareonthaitawee, Benoit Desjardins +15 more

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma

UNC Libraries(2024)10.17615/7zap-4733
N/A
0DataRank · unranked
0 citations

Barry Keane, David Mauro, Menggang Yu, Bert H. O’Neil, Paul R. Helft +6 more